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Summary (149 words)  
PDGFRA/ NG2 – expressing glia are distributed throughout the adult central nervous system 
(CNS).  They are descended from oligodendrocyte precursors (OLPs) in the perinatal CNS but 
it is not clear whether they continue to generate myelinating oligodendrocytes or other 
differentiated cells during normal adult life.  We followed the fates of adult OLPs in Pdgfra-
CreERT2/Rosa26-YFP double-transgenic mice.  We found that OLPs generate many myelinating 
oligodendrocytes during adulthood; >20% of all oligodendrocytes in the adult corpus callosum 
were generated after seven weeks of age, raising interesting questions about the function of 
the late-myelinating axons.  OLPs also produced some myelinating cells in the cortex but the 
majority of adult-born cortical cells did not appear to myelinate.  We found no evidence for 
astrocyte production in grey or white matter.  However, small numbers of projection neurons 
were generated in the forebrain - especially in the piriform cortex, which is the main target of 
the olfactory bulb. 
 
Introduction 
Oligodendrocytes, the myelin-forming cells of the central nervous system (CNS), are mostly generated 
during the first few postnatal weeks in rodents, peaking in the second week (P7-P14).  They 
differentiate from proliferative, migratory oligodendrocyte precursors (OLPs) that originate in the 
ventricular zones (VZ) of the developing spinal cord and brain.  OLPs express a characteristic set of 
markers, including the platelet-derived growth factor alpha-receptor (PDGFRA) and the NG2 
proteoglycan, allowing OLP development to be followed in situ.  Both PDGFRA and NG2 are rapidly 
down-regulated when OLPs differentiate into oligodendrocytes 1-3, unlike other lineage markers (e.g. 
transcription factors SOX10, OLIG2) that are expressed in both OLPs and oligodendrocytes.  By the 
time of birth, OLPs are more-or-less evenly distributed throughout the brain, both in grey matter and 
developing white matter, and remain so during the early postnatal period when oligodendrocyte 
production is in full swing.  The size of the OLP population remains relatively stable throughout this 
time, presumably because, although OLPs continue to proliferate, half of the daughter cells either 
differentiate or die. 
 
A population of glial cells with the characteristics of OLPs persists into adulthood 3-9.  These “adult 
OLPs” are scattered through the grey and white matter and comprise ~4% of all cells in the adult 
rodent CNS 6, 9.  At least some of these are dividing cells and there is some evidence that they can 
differentiate into oligodendrocytes during adulthood 9, 10, although it remains to be shown whether or 
not they myelinate axons.  Adult OLPs have a complex morphology and extend processes to 
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synapses 11, 12 and nodes of Ranvier 13, suggesting that they might monitor and perhaps modulate 
electrical activity in neurons.  The finding that OLPs in some parts of the adult CNS receive synaptic 
input from neurons 14 also points towards a role in normal CNS physiology.  It seems possible that 
adult OLPs might fulfill a dual role, participating in information processing as well as acting as a 
reservoir of new oligodendrocytes throughout life.  Indeed, their precursor role might not be restricted 
to oligodendrocytes, because OLPs (“O-2A progenitors”) from perinatal rat optic nerves can also give 
rise to astrocytes and neurons under certain culture conditions 15, 16.  To reflect their potentially diverse 
functions and the fact that they have multiple cell processes, adult OLPs have also been named 
“polydendrocytes” 17.  Another name, “synantocyte” was coined on the basis of their close contacts 
with neurons 8.  They are also referred to simply as “NG2 cells” or “NG2 glia”. 
 
To determine the behaviour and fates of adult OLPs in vivo, we generated a transgenic mouse line 
that expresses a tamoxifen-inducible form of the Cre recombinase (CreERT2) under PDGFRA 
transcriptional control in a phage artificial chromosome (PAC).  The PAC transgene was faithfully 
expressed by OLPs in the postnatal CNS.  By combining Pdgfra-CreERT2 mice with the Rosa26-YFP 
reporter line we were able to induce expression of yellow fluorescent protein (YFP) de novo in adult 
OLPs and identify their differentiated progeny.  We found that OLPs generate mature, myelinating 
oligodendrocytes in adult mice up until at least eight months of age, raising interesting questions about 
the function of the newly-myelinated axons.  We were unable to find any evidence for astrocyte 
production from adult OLPs in either grey or white matter.  Intriguingly, we found small numbers of 
YFP-labelled neurons in the forebrain, particularly in the piriform cortex (primary olfactory cortex).  The 
YFP+ cortical neurons accumulated with time post-tamoxifen, consistent with their being generated 
continuously from PDGFRA-expressing precursors.  They did not express interneuron markers but 
resembled projection neurons.  We did not find any YFP-labelled interneurons in the olfactory bulb, 
reflecting the fact that our Pdgfra-CreERT2 transgene is not active in multipotent stem cells of the 
forebrain subventricular zone (SVZ).  We also did not observe significant numbers of piriform neurons 
in fate-mapping experiments with Fgfr3-iCreERT2, which specifically targets SVZ stem/progenitor cells 
and astrocytes.  We conclude that the new neurons we observe are likely to be generated by 
PDGFRA-expressing adult OLPs/ NG2 cells in the parenchyma. 
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Materials and methods 
 
Pdgfra-CreERT2 and Fgfr3-iCreERT2 transgenic mice 
Generation and characterization of BAC transgenic mice is described in Supplementary Fig. 1 online 
(Pdgfra-CreERT2) and Supplementary Fig. 3 online (Fgfr3-iCreERT2). 
 
Tamoxifen induction 
Homozygous CreERT2 mouse lines were maintained on the Rosa26-YFP reporter background 18.  Cre 
recombination was induced by administering tamoxifen (Sigma, 40 mg/ml), dissolved in corn oil by 
sonication for 45 minutes at 30°C.  Adult mice were given 300 mg/Kg body weight by oral gavage on 
each of four consecutive days starting at P45 or P180.  In the corpus callosum of Pdgfra-CreERT2/ 
Rosa-YFP mice 45 ± 1% of PDGFRA+ OLPs became YFP-labelled; in the medial cortex 49 ± 2% were 
labelled (means ± s.d., combining data from mice induced at P45 and analyzed 8, 14, 28 or 90 days 
post-tamoxifen) (Fig. 3d).  In Fgfr3-iCreERT2/Rosa26-YFP mice, practically all cells in the forebrain 
SVZ (including GFAP-positive type-B cells) and a high proportion of Fgfr3-expressing astrocytes in the 
parenchyma 19 became YFP-labelled (Supplementary Fig. 3 online). 
 
BrdU labelling 
For the two-hour time point, BrdU (20 mg/ml in PBS) was administered as a single 2 mg intra-
peritoneal injection two hours prior to perfusion.  For cumulative labelling, mini-pumps (Alzet) were 
loaded with 50 mg/ml BrdU (Sigma) in 1% ammonium solution or vehicle alone and implanted 
subcutaneously into adult mice 20.  Mini-pumps were weighed before and after filling to confirm 
successful loading then primed at 37ºC in 0.9% (w/v) saline for at least an hour prior to implantation.  
They were replaced after nine days.  Alternatively, BrdU was added to the drinking water (1 mg/ml).  
Both modes of delivery gave similar data (Fig. 2e, f). 
 
Tissue preparation 
Mice were anaesthetized with pentobarbitone and perfused through the ascending aorta, first with 
0.9% (w/v) saline then with 4% (w/v) paraformaldehyde (PFA, Sigma) in PBS.  Brains were removed 
and immersed in 4% PFA in PBS for 45 minutes at room temperature (required for anti-PDGFRA) or 
else overnight at 4°C (required for anti-SOX10 or -OLIG2).  Other antibodies, including anti-GFP and 
anti-NG2, tolerated short or long fixation.  Tissue was cryo-protected overnight at 4ºC in 
diethylpyrocarbonate-treated 20% (w/v) sucrose in PBS, embedded in Tissue-Tek OCT compound, 
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frozen on dry ice and stored at -80ºC.  Cryo-sections (14, 20 or 30 µm) were floated onto the surface 
of PBS, or collected onto gelatin-coated slides and dried overnight at room temperature. 
 
Immunohistochemistry 
Sections were pre-treated with blocking solution [10% (v/v) sheep serum, 0.1% (v/v) Triton X-100 
(BDH) in PBS]  for one hour at room temperature, then incubated sequentially in primary antibody and 
secondary antibody containing Hoechst 33258 dye (Sigma, 104 dilution), all in blocking solution.  After 
washing in PBS floating sections were transferred to Superfrost Plus slides and dried.  All slides were 
coverslipped in mounting medium (Dako) and examined under the fluorescence microscope.   Primary 
antibodies used in this study were: anti-PDGFRA (rat, BD Sciences Ltd., 1:500 dilution), -GFP (rabbit, 
AbCam, 1:6000 or rat, Fine Chemical Products Ltd., 1:2000), -SOX10 (guinea pig, a gift from M. 
Wegner, 1:4000), -GFAP (mouse, Sigma, 1:2000), -NeuN (mouse, Chemicon, 1:1000), -S100β 
(mouse, Sigma, 1:400), -Doublecortin (guinea pig, Chemicon, 1:3000); -PSA-NCAM (mouse IgM, 
Chemicon, 1:1000), -CNPase (mouse, Chemicon, 1:2000), -NG2 (rabbit, Chemicon, 1:500), -MBP (rat, 
AbD Serotec, 1:100), -nNOS (rabbit, Zymed, 1:500), -Reelin (mouse, a gift from A. Goffinet, 1:2000), -
MAP2a2b (mouse, Sigma, 1:500), -Tau1 (mouse, Chemicon, 1:200), -Neurofilament (mouse, 
Chemicon, 1:500), -Olig2 (rabbit, Chemicon, 1:700), -BrdU (mouse, American Type Culture Collection, 
1:10 or rat, AbD Serotec, 1:500).  All mouse or rat antibodies were monoclonal.  Antibodies against 
Calbindin, Calretinin, Somatostatin, Parvalbumin, Tyrosine Hydroxylase and Neuropeptide-Y were 
described previously 21, 22.  Secondary antibodies were Alexa Fluor 488-, 568- or 647-conjugated goat 
anti-mouse IgG1, goat anti-mouse IgM, goat anti–rabbit IgG (Invitrogen, 1:1000), goat anti-rat IgG 
(Invitrogen, 1:500), Cy3-conjugated goat anti-guinea pig IgG (Chemicon, 1:500) or anti-mouse TRITC 
(Jackson Labs., 1:200).  BrdU immunolabelling was as described previously 22. 
 
Dye-filling live or fixed cells 
Dye-filling live cells (“live-filling”) was as follows:  300 µm live brain slices of tamoxifen-induced Pdgfra-
CreERT2/Rosa26-YFP mice were prepared using a vibratome.  YFP+ cell bodies (not processes) were 
visible in the two-photon laser scanning microscope at 930 nm excitation wavelength.  Positive cells 
were filled with 20 µM Alexa Fluor 488 dye through a 9-12 MΩ glass pipette.  Alternatively, for “fix-
filling”, perfusion-fixed tissue was post-fixed by immersion overnight at 4°C in 4% PFA and 90 µm 
vibra-slices were collected on to the surface of PBS and immunolabelled for YFP as described above, 
but in the absence of Triton X-100.  DiI 0.1% (w/v) was delivered into YFP+ cells by iontophoresis 
using a 10-15 MΩ pipette and a 10-30V pulse.    All YFP-positive cells in a given microscopic field 
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were DiI-filled.  Images of cells before and after filling were collected using custom-made ScanImage 
software and analyzed with ImageJ (http://rsbweb.nih.gov/ij/). 
 
Microscopy and quantification 
Confocal images were captured with an UltraView microscope (Perkin Elmer) using standard 
excitation and emission filters for visualizing DAPI, FITC (Alexa Fluor 488), CY3, TRITC (Alexa Fluor 
568) and Far Red (Alexa Fluor 647).  Confocal Z-stacks were captured for each section (0.5-1 µm 
increments).  XZ and YZ views were reconstructed using Volocity software (Perkin Elmer).  For cell 
counting, micrographs were made using a x10 objective on a Zeiss Axioplan microscope with 
Hamamatsu digital camera or x20 objective in the Ultraview confocal.  Composite images were 
assembled using Adobe Photoshop and defined areas were measured using Carl Zeiss AxioVision 
Release 4.5.  Quantification of YFP labelled cells was concentrated in the anterior forebrain: 
neocortex, corpus callosum and anterior piriform cortex at Bregma levels 0-0.26 mm 23.  Sections from 
at least three mice were analyzed for each data point. 
 
Results 
Antigenic characterization of adult OLPs  
Adult OLPs are usually characterized as NG2-positive, process-bearing cells in the grey and white 
matter.  We confirmed by immunolabelling that practically all non-vascular NG2-expressing cells in the 
adult brain co-express PDGFRA and vice versa (Fig. 1).  For example, 99.6% ± 0.4% of NG2+ OLPs 
in the corpus callosum co-expressed PDGFRA (mean ± s.d., >1000 cells total from three mice) 
(Fig. 1a, b, e).  These two OLP markers could therefore be used interchangeably; this was useful 
because our anti-PDGFRA worked only in short-fixed tissue whereas anti-NG2 could be used in short- 
or long-fixed material.  We co-labelled with anti-NG2 and anti-SOX10, which works only in long-fixed 
tissue (see Methods), and found that all non-vascular NG2+ cells co-expressed SOX10 (no SOX10-
negative cells out of >1000 NG2+ cells scored in corpus callosum (CC) or cortex, three sections from 
each of three mice) (Fig. 1c, e).  There were, however, many (SOX10+, NG2-negative) cells, 
especially in white matter, that are presumably differentiated oligodendrocytes (Fig. 1c, e).  All 
SOX10+ cells were also OLIG2+ in CC and cortex, so OLIG2 could be used interchangeably with 
SOX10 as a general oligodendrocyte lineage marker in long-fixed material (Fig. 1d, e).  However, anti-
OLIG2 labelled only a subset of PDGFRA+ cells in short-fixed tissue (not shown), so our anti-OLIG2 
could not be used for short-fixed material. 
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Two subpopulations of adult OLPs – cycling versus non-cycling 
Adult OLPs are the major dividing cell population in the adult rat CNS 9.  However, neither the 
proportion of cells in cycle (growth fraction) nor their cell division times have been determined.  To 
gain a more detailed understanding of the cell cycle dynamics of adult OLPs we performed cumulative 
BrdU labelling experiments 20, 24.  BrdU was administered to young adult mice continuously for up to 21 
days, either in the drinking water or via osmotic mini-pumps inserted under the skin, starting on 
postnatal day 60 (P60).  Coronal forebrain sections were analyzed after various BrdU labelling periods 
by double immunohistochemistry for BrdU and PDGFRA (Fig. 2a-d).  We calculated the labelling 
index (fraction of PDGFRA+ cells that incorporated BrdU) separately for cells in the CC and the medial 
(mainly motor) cortex.  Both routes of BrdU delivery gave similar results and are plotted together in 
Fig. 2e, f.  In the CC, the labelling index (LI) increased with time for 7-10 days but then reached a 
plateau at LI ≈ 0.55 (Fig. 2e).  This implies that the cell cycle time is of the order of one week and that 
only ~50% of the PDGFRA+ cells are actively engaged in the cell cycle – i.e. there are separate 
dividing and non-dividing subpopulations of OLPs in the adult CC. 
 
In the cortex, the LI increased steadily over the labelling period (Fig. 2f).  At 21 days nearly 40% of 
PDGFRA+ cells in the cortex had incorporated BrdU.  If the LI continues to increase at the same rate 
until all cortical OLPS are labelled, then that would imply that the whole population divides with an 
average cycle of ~50 days.  However, with the data available we can conclude only that 40% or more 
of cortical adult OLPs are dividing with an average cell cycle time of at least 21 days. 
 
We counted PDGFRA+ adult OLPs in the cortex and CC in 14 µm sections as a function of age.  
Between P45 and P135 there were no significant changes in the numbers of cells per unit area 
(Fig. 2g).  Since a proportion of adult PDGFRA+ OLPs divides every 7-10 days on average in the CC, 
yet the population does not increase, it follows that half the daughters of OLP divisions must either die, 
or differentiate and down-regulate PDGFRA. 
 
Adult OLPs differentiate in grey and white matter 
To follow the fates of PDGFRA+ adult OLPs we generated a transgenic line that expresses a 
tamoxifen-inducible version of Cre recombinase (CreERT2) under Pdgfra transcriptional control 
(Supplementary Fig. 1 online).  In situ hybridization revealed that CreERT2 RNA transcripts were 
expressed in scattered cells throughout the postnatal brain, like endogenous Pdgfra transcripts 
(Supplementary Fig. 1 online).  Double-label in situ hybridization showed that there was near-
complete overlap between Pdgfra and Cre expression in the neocortex, piriform cortex, hippocampus 
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and striatum (>99% of Cre-expressing cells co-expressed Pdgfra in these locations).  In the CC, 
where in situ hybridization was less sensitive, >95% of Cre-expressing cells expressed detectable 
Pdgfra (Supplementary Fig. 1 online). 
 
We administered tamoxifen to P45 Pdgfra-CreERT2/Rosa26-YFP double-transgenic offspring and 
immunolabelled for YFP and PDGFRA at various times post-tamoxifen.  At the earliest time examined 
(three days after the first dose of tamoxifen, P45+3) 89% ± 10% of YFP-expressing cells in the CC co-
labelled for PDGFRA and NG2 (mean ± s.d., >400 cells total, nine sections from three mice)  
(Fig. 3a-c, e).  This proportion fell at longer times post-tamoxifen as more YFP-labelled cells 
differentiated and lost PDGFRA expression (Fig. 3e).  Only 45-50% of PDGFRA+ cells became YFP-
labelled (Fig. 3d), presumably because of inefficiency of the tamoxifen induction protocol.  We tested 
whether Cre recombination might have occurred preferentially in the dividing or non-dividing sub-
populations of OLPs, by administering BrdU to tamoxifen-induced mice (P60) via their drinking water 
before counting (YFP+, PDGFRA+, BrdU+) triple-labelled cells.  The fraction of (YFP+, PDGFRA+) 
cells that became BrdU-labelled was comparable to that of the PDGFRA+ population as a whole, in 
both CC and cortex (Fig. 3i, j). 
 
When Pdgfra-CreERT2/Rosa26-YFP mice were analyzed 5 to 28 days post-tamoxifen the number of 
YFP+ cells increased in both CC and cerebral cortex and an increasing fraction of them were 
PDGFRA-negative (Fig. 3e, g, h) - as expected if a proportion of OLPs is proliferating and 
differentiating.  We counted YFP+, PDGFRA-negative cells in medial cortex and CC from five days to 
three months after administering tamoxifen at either P45 or P180.  In both brain regions the number of 
these cells increased with time, though at different rates – slower rates of increase in P180 versus P45 
animals and in medial cortex versus CC at either age (Fig. 3f).  We initially counted male and female 
mice separately but, as there were no major differences (Supplementary Fig. 2 online), data from 
both sexes are combined in Fig. 3d-f. 
 
Many new myelinating oligodendrocytes are formed in adult white matter 
All YFP-labelled cells in the CC were also SOX10-positive when examined up to 210 days post-
tamoxifen (no SOX10-negative cells found among >1500 YFP+ cells scored across three mice at 
P45+210; Fig. 3k, l), identifying them as oligodendrocyte lineage cells.  We found that 13.0 ± 1.7% of 
all SOX10+ cells were YFP+ at P45+90 (mean ± s.e., >2700 SOX10+ cells scored in three mice).  
Since ~45% of OLPs were YFP-labeled in our mice at P45 (Fig. 3d and Methods) and ~60% of YFP+ 
cells in the P45+90 CC were PDGFRA-negative oligodendrocytes (Fig. 3e) this implies that ~17% of 
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oligodendrocytes in the P135 CC were generated between P45 and P135 
[i.e. {(13.0 ± 1.7%) x 0.6} ÷ 0.45 = 17.3 ± 2.3%].   At P45+210, 17.1 ± 2% of SOX10+ cells were YFP+ 
(>3000 SOX10+ cells scored in four mice).  Of these, 77 ± 2% were PDGFRA-negative 
oligodendrocytes (Fig. 3e) so, assuming that only 45% of OLPs were YFP-labeled at the start of the 
experiment, this implies that ~29% of differentiated oligodendrocytes are formed in the CC between 
P45 and P255 [i.e. {(17.1 ±  2%) x 0.77} ÷ 0.45 = 29.3 ± 3%]. 
  
The majority of YFP+, PDGFRA-negative cells in the CC had multiple parallel fine processes 
reminiscent of the cytoplasmic tongue processes of myelinating oligodendrocytes  25 (Fig. 4a).  These 
were aligned with neurofilament (NF)-positive axons (Fig. 4b).  The cell bodies and proximal 
processes of YFP+, PDGFRA-negative cells in the CC at P45+8 or P45+10 could be immunolabelled 
for 2’, 3’-cyclic nucleotide phosphodiesterase (CNP) or myelin basic protein (MBP), indicating that they 
were synthesizing myelin (Fig. 4c, d, k).  In contrast, PDGFRA+ OLPs did not express detectable 
amounts of CNP in either the CC or cortex (Fig. 4e, f and not shown).  Cell bodies of (YFP+, SOX10+, 
CNP+) cells were also found in the CC at later times post-tamoxifen (e.g. P45+210; Fig. 4g), but there 
was very little YFP/MBP co-localization in this material (not shown), presumably because MBP protein 
is present mainly in the myelin sheaths whereas YFP, being a large cytoplasmic protein, is physically 
excluded from compact myelin. 
 
If differentiated oligodendrocytes are formed during adulthood from dividing OLPs as implied above, 
then we should be able to label the differentiated cells in BrdU pulse-chase experiments.  We 
tamoxifen-treated Pdgfra-CreERT2/Rosa26-YFP mice for four days starting on P60, added BrdU to 
their drinking water for 21 days starting on P67, then after a further 53 days (P140) immunolabeled for 
BrdU, YFP and either PDGFRA or CNP.  As predicted, many (YFP+, PDGFRA-negative) cells and 
(YFP+, CNP+) cells were also BrdU-positive (Fig. 4i, j) (e.g. in CC, 85 ± 4% of YFP+, PDGFRA-
negative cells were BrdU+ ; in cortex, the figure was 68 ± 20%; >100 YFP+ cells counted in three 
sections from three mice). 
 
To visualize whole cell morphology and determine whether YFP-labelled cells could indeed generate 
myelin internodes, we injected the low molecular weight fluorescent dye Alexa Fluor 488 26 into 
individual YFP-labelled cell bodies in live forebrain slices (300 µm) and observed the dye-filled cells in 
the two-photon microscope.  Some dye-filled cells in the CC, presumed to be adult OLPs, had multiple 
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spidery processes (Fig. 5a, b).  Other dye-labelled cells had the typical striking morphology of 
myelinating oligodendrocytes, elaborating up to ~50 rod-like myelin internodes (Fig. 5c, d). 
 
The number of live dye-filled cells that could be analyzed in a given slice was limited because cell 
morphology deteriorated rapidly in unfixed tissue.  To analyze larger numbers of cells we turned to 
filling cells in tissue slices that had been previously fixed and immunolabelled for YFP (fixation 
destroys the intrinsic YFP fluorescence) (“fix-filling”; see Methods).  A drawback of this approach was 
that dye penetration into fine cellular processes (including myelin internodes) was reduced, compared 
to live-filling.  Nevertheless, we were able to distinguish cells with “progenitor” morphology (Fig. 5i) 
from those with “myelinating” morphology (Fig. 5j) and determined that the proportion of the latter 
increased with time post-tamoxifen (Fig. 5k).  At P45+12, 6/57 (~10%) of dye-filled YFP+ cells in the 
CC had myelinating morphology whereas at P45+75 the proportion was 48/71 (~70%) (Fig. 5k).  This 
is in keeping with our observation that ~62% of YFP+ cells in the CC were differentiated (PDGFRA-
negative) at P45+90 (since Fig. 3e shows that ~38% of YFP+ cells were PDGFRA+).  Finally, to 
confirm the identity of the “myelinating” cells, we immunolabelled with anti-MBP and showed that dye-
filled processes also contained MBP (Fig. 5l). 
 
Myelinating and non-myelinating oligodendrocyte lineage cells in the cortex 
All YFP+ cells in the medial (motor) cortex were also SOX10+ up to P45+210, identifying them as 
oligodendrocyte lineage (99.8 ± 0.3% at P45+210; mean ± s.d., >1000 SOX10+ cells scored in nine 
sections from three mice).  The great majority of live dye-filled YFP+ cells in the neocortex had typical 
OLP morphology (Fig. 5e, f).  Cells with many thin processes, some of which resembled rigid myelin 
internodes, were found in the deeper layers of the cortex (layers 5/6) (Fig. 5g, h) but these were 
infrequent - we found 5 cells with putative internodes among a total of 95 live dye-filled YFP+ cells (of 
the order of 5%, Fig. 5k).  We also found (YFP+, SOX10+, CNP+) cell bodies in the cortex (Fig. 4h) 
and occasional (YFP+, MBP+) cell processes (Fig. 4l) - indicating that myelin-producing cells are 
formed at low frequency in the cortex during adulthood.  The fraction of YFP+ cells that was CNP+ at 
P45+210 was 21 ± 4% (450 YFP+ cells scored in six sections from three mice).  NG2+ OLPs in the 
cortex never expressed detectable CNP (Fig. 1e). 
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Lack of evidence for astrocyte production from adult OLPs 
We did not find any cells that co-immunolabelled for YFP and glial fibrillary acidic protein (GFAP), 
either in grey or white matter (e.g. no GFAP+ cells were found among >1800 YFP+ cells scored in the 
cortex and >2200 cells in the CC, nine sections from three mice) (Fig. 6a-d).  Because most 
astrocytes in grey matter do not express detectable GFAP protein we immunolabelled for YFP and 
S100β, which is often regarded as a marker of grey matter (protoplasmic) astrocytes although it is also 
known to be expressed by some oligodendrocyte lineage cells in the mouse 27.   We did find some 
(YFP+, S100β+) cells in both the cortex and CC at all times examined post-tamoxifen.  However, at 
P45+8 the double-positive cells in cortex frequently co-labelled for PDGFRA, suggesting that S100β is 
expressed by a subset of OLPs (Fig. 6e).  At later times post-tamoxifen (P45+90 or P45+210) there 
were increasing numbers of (YFP+, S100β+) cells that were PDGFRA-negative; however, they all co-
labelled for SOX10, identifying them as oligodendrocyte lineage (Fig. 6f).  At P45+210, 
(YFP+, S100β+) cells accounted for 10.3 ± 1% of all YFP+ cells in the CC and 12.2 ± 3.7% of YFP+ 
cells in the medial cortex (mean ± s.d., 1100 YFP+ cells scored in the CC and 700 in the cortex from 
three mice). 
 
Even if there were YFP-labelled protoplasmic astrocytes in the cortex that did not express GFAP or 
S100β, we would almost certainly have been able to identify them by morphology alone.  In 
Fgfr3-iCreERT2/Rosa26-YFP mice many protoplasmic grey matter astrocytes are labelled 
(Supplementary Fig. 3 online); the latter have a small cell body surrounded by a “cloud” of extremely 
fine processes, distinct from the less numerous branched processes of adult OLPs.  This also 
demonstrates that the Rosa26-YFP reporter is active in differentiated astrocytes, so our failure to 
detect YFP-labelled astrocytes in Pdgfra-CreERT2/Rosa26-YFP mice is unlikely to be due to down-
regulation of the reporter. 
 
Most adult-born oligodendrocytes are derived from local OLPs, not the SVZ 
The CC lies close to the forebrain SVZ, raising the possibility that some or all adult-born 
oligodendrocytes might be generated directly from stem/progenitor cells in the SVZ, some of which 
have been reported to express PDGFRA 28.  However, our Pdgfra-CreERT2 mice do not drive 
recombination in SVZ cells, possibly because our Pdgfra PAC clone is lacking essential regulatory 
elements.  Immunolabelling Pdgfra-CreERT2/Rosa26-YFP mice for YFP and GFAP did not reveal any 
double-labelled subependymal astrocytes (type-B cells) in the SVZ.  Similarly, immunolabelling for 
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YFP together with polysialated Neural Cell Adhesion Molecule (PSA-NCAM), Doublecortin (DCX) or 
NeuN did not reveal any migratory neuroblasts or neurons in the SVZ, rostral migratory stream or 
olfactory bulbs (Supplementary Fig. 3 online and not shown).  Moreover, no YFP-labelled 
neurospheres developed in SVZ cell cultures derived from these mice.  Note that (YFP+, PDGFRA+) 
and (YFP+, PDGFRA-negative) cells were found in the SVZ but these were invariably SOX10+, 
marking them out as committed oligodendrocyte lineage cells.  Similarly, all YFP+ cells in the olfactory 
bulbs were SOX10+ (Supplementary Fig. 3 online) 
 
Analogous experiments with Fgfr3-iCreERT2/Rosa26-YFP mice contrasted sharply with the above.  We 
found that all SVZ cells, including all GFAP+ type-B cells, were labelled in these mice, many YFP+ 
neurospheres developed in SVZ cell cultures and many (YFP+, NeuN+) neurons appeared in their 
olfactory bulbs (Supplementary Fig. 3 online).  However, we found only small numbers of 
(YFP+, SOX10+) oligodendrocyte lineage cells in the CC at P45+90.  These accounted for only 0.23 ± 
0.03% of all SOX10+ cells in the CC (mean ± s.d., >8000 SOX10+ cells total, at least three sections 
from each of three mice), compared to ~20% in Pdgfra-CreERT2/Rosa26-YFP mice under similar 
experimental conditions (see previous section).  We conclude that the great majority of 
oligodendrocytes formed in the CC over the 90 days of our experiments are derived from local 
PDGFRA+ OLPs/NG2 cells that are already resident in the CC prior to P45, not from type-B cells in 
the SVZ either directly or indirectly through intermediate OLPS. 
 
Evidence that adult OLPs generate projection neurons in the piriform cortex 
Starting around a month post-tamoxifen (P45+28), small numbers of YFP-labelled cells that did not 
co-label for SOX10, OLIG2, PDGFRA or NG2 were observed in the piriform cortex and other parts of 
the ventral forebrain of Pdgfra-CreERT2/Rosa26-YFP mice (Fig. 7a, c-e).  We focused our analysis on 
the anterior piriform cortex (aPC), layers 2/3.  The YFP+, SOX10-negative cells expressed the 
neuronal marker NeuN (Fig. 7b-e, j, l) and they increased in number between 28 and 210 days post-
tamoxifen (Fig. 7f).  Many of the (YFP+, NeuN+) cells had the appearance of projection neurons with 
large cell bodies and long axon-like processes (Fig. 7a, h, j and Fig. 8a, c-h).  The long processes 
could be immunolabelled with anti-MAP2 or anti-TAU1, which label dendrites and axons respectively, 
although it was difficult to distinguish individual processes within the dense mesh of MAP2/TAU1 
immunolabelling in the piriform cortex (Fig. 7g-i).  Nevertheless, we could determine that the (YFP+, 
TAU1+) processes (putative axons) projected towards the pial surface.  The YFP+ neurons could not 
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be co-immunolabelled for Neurofilament, Reelin or neuronal Nitric Oxide Synthase (nNOS), nor any of 
the interneuron markers Calbindin, Calretinin, Neuropeptide-Y, Parvalbumin, Somatostatin or Tyrosine 
Hydroxylase (Supplementary Fig. 4 online and not shown). 
 
One possibility is that the YFP+ projection neurons are generated from the local population of adult 
OLPs.  Alternatively, they might develop from migratory neuroblasts originating in the SVZ.  The latter 
seems very unlikely because our Pdgfra-CreERT2 transgene is not active in the SVZ (see previous 
section); nevertheless, to test the neurogenic properties of the SVZ directly we examined 
Fgfr3-iCreERT2/Rosa26-YFP mice.  There was no accumulation of (YFP+, NeuN+) cells in the aPC of 
these mice (Fig. 7f), supporting the idea that the adult neurogenesis we describe is driven mainly by 
precursor cells outside the SVZ – most likely the local population of OLPs/NG2 cells. The region of 
aPC that we analyzed spans ~2 mm in the anterior-posterior axis (~67 x 30µm coronal sections) and 
our Pdgfra-CreERT2 mice label ~50% of PDGFRA+ cells in the cortex, so we calculate that ~24 new 
long-term surviving neurons are added to the aPC each day until at least eight months of age.  [From 
Fig. 7f, YFP+ neurons are added at a rate of 0.18 cells/section/day; (0.18 x 67 ÷ 0.5) = 24.1] 
 
We asked whether the YFP+ neurons were derived from proliferating OLPs by tamoxifen-inducing 
Pdgfra-CreERT2/Rosa26-YFP mice starting on P60, then adding BrdU to their drinking water for 21 
days starting on P67.  The mice were left for a further 53 days (P60+80) before immunolabelling for 
BrdU, YFP and NeuN.  None of 243 (YFP+, NeuN+) cells examined (n=3 mice) was BrdU+, 
suggesting that they were formed from PDGFRA+ cells that had become post-mitotic before being 
exposed to BrdU (i.e. before P67) (e.g. Fig. 7j-l). 
 
Discussion 
Adult myelinogenesis  
There is good evidence that adult OLPs generate new myelinating oligodendrocytes following acute 
experimental demyelination 29, 30.  There is also evidence that they can generate oligodendrocytes 
during normal adult life 9 although the scale of adult oligodendrogenesis has not been determined, nor 
has it been established whether they generate mature, myelinating cells.  Our present experiments 
with Pdgfra-CreERT2 mice confirm that adult OLPs generate myelin-forming oligodendrocytes in the 
CC and, to a lesser extent, in cortical grey matter.  The number of new oligodendrocytes that are 
formed in the CC during the seven month period after P45 is >20% of the final total and many of these 
appear to myelinate, judging by dye-filled morphology and the fact that they express myelin proteins.  
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In contrast, only around 5% of adult-born oligodendrocyte lineage cells in the cortex elaborated myelin 
sheaths, judging by dye-filled morphology.  Around 20% of all YFP+, SOX10+ cells in the motor cortex 
were CNP+ but NG2-negative at P45+210, so it follows that a sizeable population of differentiated, 
apparently non-myelinating, oligodendrocyte lineage cells is present in the adult cortical grey matter.  
These cells might have a novel function unrelated to myelination, or they might form myelin 
infrequently or at a very low level compared to white matter oligodendrocytes.  Further work is needed 
to reveal their properties and functions. 
 
The CC is known to contain a mixture of myelinated and unmyelinated axons.  Myelination continues 
until at least P240, at which time ~70% of axons are still not fully myelinated 31.  It is possible that the 
newly formed oligodendrocytes that we observe are engaged in ensheathing these previously naked 
axons.  Alternatively, new oligodendrocytes might be formed to replace some that degenerate during 
normal life.  However, long-term tritium labelling experiments support the idea that there is modest 
accumulation of oligodendrocytes in the mouse corpus callosum during the first year, without 
detectable turnover 32.  If, as seems likely, naked axons continue to be myelinated into adulthood this 
would presumably increase their conduction velocity and alter the properties of the neural circuit(s) in 
which they participate.  The functional or behavioural consequence of this is unknown but it could 
potentially play a role in neural plasticity, such as learning and/or memory consolidation 33.  It has 
recently been shown that some adult OLPs form “en passant” synapses with axons in white matter 
and can respond to action potentials in those axons 34, 35, raising the possibility that OLPs are 
“listening in” to axonal activity, which at some threshold might trigger myelination. 
 
There is reported to be a population of (PDGFRA+, GFAP+) multipotent type-B cells in the adult SVZ 
that contributes to olfactory neurogenesis 28.  In addition, a small fraction of type-C (transit amplifying) 
cells originating in the SVZ starts to express OLIG2 and generates PDGFRA-positive OLPs and 
mature oligodendrocytes in the CC, striatum and fimbria fornix of adult mice 36.  In principle, therefore, 
the adult-born oligodendrocytes that we observed might all have developed from these cells.  
However, very few YFP+ oligodendrocytes were formed in control experiments with Fgfr3-CreERT2 
mice which mark all SVZ stem/progenitor cells but not OLPs.  This indicates that the great majority of 
adult-born oligodendrocytes differentiate from local OLPs – consistent with the observation that adult 
OLPs divide yet their numbers do not increase.  Experimental demyelination has been shown to 
activate cell division and migration from the SVZ, so SVZ-derived precursors might become more 
important during myelin repair 36-38. 
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We did not detect any astrocyte production from PDGFRA+ OLPs in the adult, either in the grey or 
white matter.  This contrasts with the recent report that some GFP-labelled protoplasmic astrocytes 
developed in the ventro-lateral forebrain of NG2-Cre/ CAGG-Z/EG double-transgenic mice 39.  
Because a constitutively active form of Cre was used in that study, it identified cells that formed mainly 
in the embryonic and early postnatal period.  It is possible, therefore, that NG2+ precursors generate 
astrocytes during embryonic development but not in the adult.  We cannot test this using our existing 
Pdgfra-CreERT2 mice, because they display ectopic transgene expression in the dorsal neural tube 
before birth (not shown).  Alternatively, it is conceivable that there are astrocyte precursors among the 
~50% of PDGFRA+ OLPs that were not YFP-labelled in our experiments. 
 
Distinct sub-populations of adult OLPs 
An unexpected finding of the present study was that there appear to be two populations of OLPs in the 
postnatal CC.  At P60, ~50% of OLPs are cycling with an average period of around one week while 
the remaining OLPs are quiescent, or dividing much more slowly.  Our BrdU cumulative labelling data 
show that in the cortical grey matter at least 40% of OLPs are dividing with a cycle longer than three 
weeks, possibly much longer - consistent with long term retroviral tracing experiments (Levison et al., 
1999) suggesting that oligodendroglial cell doubling time in the adult rat cortex is around three months. 
 
There have been previous hints that OLPs are heterogeneous 40 41-43.  It will be intriguing to discover 
whether mitotic activity co-segregates with any of the reported subclasses of OLPs and, if so, the 
biological significance of the link. 
 
Adult neurogenesis in the pirifom cortex 
We have presented evidence that adult OLPs generate small numbers of neurons throughout the 
ventral forebrain but particularly in the piriform cortex (also known as the primary olfactory cortex), the 
primary projection site of the olfactory bulbs.  These neurons did not express known interneuron 
markers (Calbindin, Calretinin, Neuropeptide-Y, Parvalbumin, Somatostatin, Tyrosine Hydroxylase) 
but had the appearance of projection neurons, with large cell bodies and long axons.  Recently, two 
morphologically and physiologically distinct types of output neurons - semilunar (SL) and superficial 
pyramidal (SP) neurons - have been described in the piriform cortex 44.  The morphologies of the 
YFP+ neurons that we describe and their location in layers 2a/2b of the aPC are compatible with the 
idea that they might be a mixture of SL and SP neurons.  However, detailed electrophysiology would 
be required to test this. 
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SOX10-negative, NeuN-positive cells first appeared in small numbers about a month after tamoxifen 
induction, increased around ten-fold over the following three months and continued to accumulate 
after that.  No YFP-labelled cells of any kind were ever observed in the absence of tamoxifen.  The 
data therefore suggest strongly that the new neurons were formed over an extended period from 
progenitor cells that became YFP-labelled at the time of tamoxifen induction.  We have so far been 
unable to label any YFP+ cells for DCX or PSA-NCAM, markers of migratory neuroblasts in the SVZ 
and RMS.  We have also been unable to find (BrdU+, NeuN+, YFP+) neurons, even after 21 days of 
continuous BrdU labelling followed by a long (53 day) chase, suggesting that they might be formed by 
trans-differentiation of post-mitotic cells. 
In vitro studies have shown that OLPs from perinatal optic nerve are capable of generating neurons 
and astrocytes as well as oligodendrocytes in vitro 16.  SVZ cells that expressed a CNP-GFP 
transgene (and which co-labelled for NG2) have been reported to generate GABAergic hippocampal 
neurons in vitro and in vivo 45.  In addition, there have been several reports of adult neurogenesis 
outside the olfactory bulb and hippocampus, both in rodents 42, 46-48 and primates 49, 50.  The concept of 
adult neurogenesis in “non-neurogenic” regions has remained controversial 51, 52.  We believe that our 
current study avoids several of the pitfalls inherent in previous studies; however, it might introduce 
new problems specific to Cre-lox technology.   For example, piriform neurons might express the 
Pdgfra-CreERT2 transgene in their own right.  This is unlikely because we did not observe either 
PDGFRA or CreER expression in NeuN-positive neurons in the piriform cortex or anywhere else.  
Moreover, if cortical neurons did express the transgene, then YFP-labelled neurons would be 
expected to appear soon after tamoxifen treatment – not to accumulate slowly over several months as 
observed.  Another possibility is that YFP+ neurons might be formed by fusion of unlabelled neurons 
with YFP+ non-neuronal cells but this also is difficult to reconcile with the delay in the appearance of 
YFP+ neurons.  Moreover, the putative cell fusion event would need to be highly cell type-specific 
because 1) we observed only YFP+ projection neurons, not cortical interneurons and 2) YFP+ 
projection neurons were not observed in Fgfr3-CreERT2/Rosa26-YFP mice, despite the fact that they 
contain many YFP+ protoplasmic astrocytes as potential fusion partners.  
In summary, we cannot absolutely rule out that the YFP+ neurons are formed by cell fusion, nor can 
we rule out that they were generated from PDGFRA-positive precursors that are distinct from adult 
OLPs – either a previously unrecognized population within the CNS or from circulating blood.  Indeed, 
there might be other unforeseen artifacts connected with the Cre-lox methodology.  However, the 
simplest scenario is that the YFP+ neurons are formed by differentiation of local, PDGFRA+ OLPs. 
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The scale of neurogenesis we observed was small.  We estimate that ~1.4% of the projection neurons 
present in layers 2/3 of the piriform cortex at eight months (P45+210) are generated after P45 [~250 
surviving (YFP+, NeuN+) neurons found in eighteen sections containing an estimated 4 x 104 NeuN+ 
projection neurons].  The physiological significance of this small amount of adult neurogenesis is 
unknown, even if the neurons in question manage to extend axons to their normal targets and form 
active connections, which we have not yet established.  It is possible that the amount of cortical 
neurogenesis might be increased by exercise or environmental enrichment, which have been shown 
to stimulate neurogenesis in the adult olfactory bulb and hippocampus.  Moreover, small numbers of 
neurons - even single neurons - are capable of eliciting observable behaviour 53, 54.  It has been 
reported that when defined cortical neurons are experimentally ablated they can be regenerated by 
endogeneous precursors and the replacement neurons can extend long-range axons towards their 
original targets 55.  Our present studies raise the possibility that those replacement neurons might be 
derived from adult OLPs/ NG2 cells; if so, the latter could be a potentially useful resource for neuronal 
replacement during neurodegenerative disease. 
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Figure Legends 
 
Figure 1.  Antigenic properties of adult OLPs/ NG2 cells 
Cryosections of young adult (P45) brain were double-immunolabelled for different combinations of 
oligodendrocyte lineage markers PDGFRA, NG2, OLIG2, SOX10 and CNP.  Representative images 
are shown in panels a-d, and cell counts (means ± s.d.) in e.  Certain antibody combinations were not 
possible (grey shading) because our anti-PDGFRA required a brief (< one hour) PFA immersion-fix 
after initial perfusion, whereas our anti-SOX10 and anti-OLIG2 required overnight fixation.  Other 
combinations were not possible (“nd”) because the available antibodies were incompatible.  Excluding 
vascular cells, essentially all PDGFRA+ OLPs were co-labelled for NG2 and vice-versa, both in CC 
and cortex.  NG2+ OLPs all co-labelled for SOX10, but not all SOX10-positive cells were NG2+ 
because SOX10 continues to be expressed in differentiated oligodendrocytes whereas NG2 (and 
PDGFRA) are down-regulated rapidly during differentiation.  Scale bars: 50 µm (a), 10 µm (b-e). 
 
Figure 2.  Cumulative BrdU labelling of adult OLPs/ NG2 cells in vivo. 
BrdU was administered to young adult (P60) mice for up to 17 consecutive days via osmotic mini-
pumps or by including BrdU in the drinking water for up to 21 days (see Methods).  Double-
immunolabelling brain sections for BrdU and PDGFRA revealed double-positive (replicating) OLPs in 
both CC and cerebral cortex (Ctx) (a-d).  Both routes of BrdU delivery gave comparable data.  In CC 
the BrdU labelling index (LI) increased to ~0.55 within 7-10 days but did not increase further (e).  In 
the cortex, LI increased linearly for 21 days until ~40% of OLPs were BrdU+ (f).  At each time point LI 
was determined from cell counts (means ± s.d.) on at least three sections from each of three animals.  
The two-hour time point is from a single intra-peritoneal injection of BrdU (see Methods).  (g) Numbers 
of PDGFRA-positive OLPs per unit area were counted in CC and cortex at P45 and P135 (14 µm 
sections).  There was no significant change in OLP cell number or density between these ages.  
Scale bars: 45 µm (a), 15 µm (b, d), 40 µm (c). 
 
Figure 3.  PDGFRA+ adult OLPs generate differentiated oligodendrocyte lineage cells. 
Sections of P45 tamoxifen-induced Pdgfra-CreERT2/Rosa26-YFP mice were immunolabelled for YFP 
and PDGFRA or NG2 at P45+5 (a-c) [arrows in a indicate YFP+, PDGFRA+ OLPs (yellow), 
arrowhead indicates a PDGFRA+, YFP-negative OLP (red)].  The fraction of PDGFRA+ cells that co-
expressed YFP increased between P45+5 and P45+8 then remained constant until at least P45+90 
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(d), indicating that Cre recombination continues for one to four days after the final dose of tamoxifen.  
With our protocol ~45% of OLPs became YFP-labelled after P45+8 (d).   The fraction of YFP+ cells 
that co-expressed PDGFRA and NG2 was high at P45+3 (e) (~87% in the CC, >95% in cortex) but 
declined with time post-tamoxifen (e), suggesting that PDGFRA+ OLPs are differentiating and down-
regulating PDGFRA.  Panel h shows one (YFP+, PDGFRA+) cell and one YFP+, PDGFRA-negative 
cell in the cortex at higher magnification.  The absolute number of YFP+, PDGFRA-negative cells 
increased with time post-tamoxifen, consistent with the idea that they are produced from dividing 
PDGFRA+ progenitors (e-h) [arrows in g indicate YFP+, PDGFRA+ OLPs (yellow), arrowhead 
indicates a YFP+, PDGFRA-negative cell (green)].  Note that all YFP-labelled cells in the CC and the 
motor cortex between P45+5 and P45+210 were SOX10+, identifying them as oligodendrocyte 
lineage cells (k, l and not shown).  The rate of addition of differentiated cells was higher at P45 than at 
P180, and higher in CC than in cortex at either age (f).  The sub-population of OLPs that became 
YFP-labelled was not biased towards either dividing or non-dividing OLPs, because the BrdU labelling 
index of (YFP+, PDGFRA+) cells matched that of the whole population of PDGFRA+ cells (i, j).    
Scale bars: 35 µm (a, g, k, l), 10 µm (b, c, h, j). 
 
Figure 4.  Evidence for myelin protein synthesis in adult-born oligodendrocytes 
Tamoxifen was administered to P45 Pdgfra-CreERT2/Rosa26-YFP mice, then forebrain sections were 
prepared and immunolabelled for YFP and PDGFRA, SOX10, CNP or MBP to identify adult-born (i.e. 
YFP+) oligodendrocyte lineage cells.  In the CC at P45+28, (YFP+, SOX10+) cells possessed many 
thin parallel cytoplasmic extensions resembling the cytoplasmic tongue processes of myelinating 
oligodendrocytes (a), which were aligned with Neurofilament (NF)-positive axons (b).  In the CC at 
P45+8, some YFP+, PDGFRA-negative cells (arrowhead in c) expressed CNP in their cell bodies and 
proximal processes (arrows in d); OLPs (YFP+, PDGFRA+) did not co-label for CNP (e, f).  Some 
YFP+ cell processes also co-labelled for MBP at P45+10 (arrows in k, l).  Cell bodies that were triple-
labelled for YFP, SOX10 and CNP were found at later times (e.g. P45+210) in the CC (g) and cortex 
(h).  However, YFP+ processes did not co-label with anti-MBP at this stage, presumably because YFP 
is sterically excluded from compact myelin.  We exposed tamoxifen-induced P60 
Pdgfra-CreERT2/Rosa26-YFP mice to BrdU via the drinking water for 21 days and analyzed them on 
P140 (see text for details).  Many (BrdU+, YFP+) cells in CC and cortex were PDGFRA-negative, 
CNP-positive (i, j and not shown), confirming that differentiated oligodendrocytes had been generated 
from dividing PDGFRA+ precursors.  Scale bars: 10 µm (a, b, c, e, k, l), 20 µm (d, f, g-j). 
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Figure 5.  Adult OLPs generate myelinating oligodendrocytes 
To reveal full cell morphology we used the intrinsic fluorescence of YFP in live tissue slices to target 
cells for Alexa Fluor dye injection via glass patch pipets.  By this means, cells with the distinctive 
morphology of myelinating oligodendrocytes, with up to 50 rod-like myelin internodes, were identified 
in the CC (c, d), as well as presumptive OLPs with slender, multiply-branching processes (a, b).  In 
the cortical grey matter, the large majority of live dye-filled cells resembled OLPs (e, f).  A few filled 
cells in cortical layers 5/6 did possess some myelin-like structures (arrowheads in g); a digital 
reconstruction gives a clearer impression of whole cell morphology (h).  To quantify the number of 
cells with myelinating morphology in the CC we filled YFP+ cells in fixed tissue slices with DiI (“fixed 
filled”; see Methods).  This allowed larger numbers of cells to be examined but the DiI did not perfuse 
the cells so completely as Alexa dye in live cells.  Nevertheless, we could distinguish cells with 
progenitor morphology (i) versus myelinating morphology (j).  The proportion of myelinating cells 
increased with time post-tamoxifen in the CC (k); at P45+75 roughly 70% of YFP+ cells had 
myelinating morphology (k).  We immunolabelled fix-filled cells with anti-MBP and showed that dye-
filled processes contained MBP, indicating that they were indeed myelin internodes (l).  Scale bars: 
10 µm. 
 
Figure 6.  Adult OLPs do not generate astrocytes 
Sections of P45+90 Pdgfra-CreERT2/Rosa26-YFP mice were immunolabelled for YFP and GFAP .  No 
double-labelled cells were observed anywhere in the CC or cortex (a-d).  Sections were also 
immunolabelled for YFP and S100β, a marker of protoplasmic astrocytes and some oligodendrocyte 
lineage cells.  In cortex, some (YFP+, S100β+) cells were present but these invariably co-labelled for 
PDGFRA (yellow arrow in e), identifying them as OLPs.  In the CC all (YFP+, S100β+) cells were 
SOX10+ (yellow arrow in f).  The white arrow in f indicates a YFP-negative, (SOX10+, S100β+) 
oligodendrocyte lineage cell and the white arrowhead indicates a YFP-negative, SOX10-negative, 
S100β+ presumptive astrocyte. Scale bars: 10 µm (b, e), 25 µm (a, c, d, f). 
 
Figure 7.  OLPs generate cortical projection neurons in vivo. 
Pdgfra-CreERT2/Rosa26-YFP mice were tamoxifen-induced at P45 and forebrain sections were 
immunolabelled at various times post-tamoxifen for YFP and various oligodendrocyte and/or neuronal 
lineage markers.  In the ventral forebrain, occasional YFP-positive, SOX10-negative cells were 
detected (arrowheads in a, c; SOX10-positive cells indicated by arrows).    These cells co-expressed 
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the neuronal marker NeuN (b-e, j, l).  Panels b are single confocal scans.  The NeuN+ cells were 
PDGFRA-negative and OLIG2-negative (arrowheads in d, e).  The field in a is from the hypothalamus 
but all other fields are from layers 2/3 of the anterior piriform cortex (aPC) [red region in panel f (inset), 
which depicts a coronal forebrain section at the level of the SVZ].  We followed the accumulation of 
(YFP+, NeuN+) cells in the aPC over time (f, numbers of neurons per 30 µm section, mean ± s.d., n=3 
mice).  Most (YFP+, NeuN+) cells appeared after a delay of 28 to 90 days and continued to 
accumulate after that.  As a control, we examined tamoxifen-induced P45 Fgfr3-iCreERT2/Rosa26-YFP 
mice, in which all SVZ stem cells and many protoplasmic astrocytes are YFP-labelled 
(Supplementary Fig. 3 online).  (YFP+, NeuN+) neurons did not accumulate in the aPC of these mice 
(f), supporting the conclusion that the adult-born neurons are formed from cells outside the SVZ.  Red 
asterisks in f indicate that the differences between the Pdgfra-CreERT2 and Fgfr3-iCreERT2 data are 
statistically significant (ANOVA, p< 0.01 and p<0.001, single and double asterisks respectively).  
Some YFP+ cell processes co-labelled for MAP2 (g) and TAU1 (h, i), although the intense 
immunolabelling for these antigens in the aPC meant that it was difficult to distinguish individual 
processes.  We were unable to label the (YFP+, NeuN+) neurons with BrdU (arrows in j, l) (see text 
for details).  A (BrdU+ YFP+) OLP acts as a control (arrowheads in j, k).  Scale bars: 10 µm (g), 
20 µm (b, d), 30 µm (a, c, e, j), 40 µm (h). 
 
Figure 8.  Morphologies of YFP-labelled neurons in the piriform cortex. 
NeuN+ neurons in Pdgfra-CreERT2/Rosa26-YFP mice were frequently located in layer 2 of the piriform 
cortex (primary olfactory cortex), with processes projecting into the lateral olfactory tract (LOT) under 
the pial surface (a, b).  In all micrographs the pial surface is top-right.  Diagram b is reproduced from 
Fig. 1 of reference 44.  Two types of principal neurons have been described in layer 2; semilunar (SL) 
neurons and superficial pyramidal (SP) neurons, which receive inputs from the olfactory bulbs via the 
LOT 44 (b).  SL neurons are often located more superficially than SP neurons (layer 2a and 2b 
respectively).  From morphology and their positions within layer 2, we speculate that the 
(YFP+, NeuN+) neurons we observe correspond to SL (c, d) and SP (e-h) neurons.  Scale bars: 
30 µm. 
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